articleTop 1% cited
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
Vaccine · 2006 · Vol. 24(27-28) · pp. 5571–5583
Luisa L. Villa✉(Ludwig Cancer Research)Kevin A. Ault(University of Iowa)Anna R. Giuliano(University of Arizona Cancer Center)Ronaldo Lúcio Rangel Costa(Instituto Brasileiro de Controle do Câncer)Carlos Alberto Petta(Universidade Estadual de Campinas (UNICAMP))Rosíres Pereira de Andrade(Centro de Reprodução Humana Prof. Franco Junior)Darron R. Brown(Indiana University School of Medicine)Alex Ferenczy(McGill University)Diane M. Harper(Dartmouth College)Laura A. Koutsky(University of Washington)Robert J. Kurman(Johns Hopkins University)Matti Lehtinen(Finnish Institute for Health and Welfare)Christian Malm(Institute for Molecular Medicine Finland)Sven-Eric Olsson(Karolinska Institutet)Brigitte M. Ronnett(Johns Hopkins Medicine)Finn Egil Skjeldestad(SINTEF)Margareta Steinwall(Lund University)Mark H. Stoler(University of Virginia)Cosette M. Wheeler(University of New Mexico)Frank J. Taddeo(United States Military Academy)Jimmy Yu(Merck (Japan))Lisa Lupinacci(Merck (Japan))Radha Railkar(Merck (Japan))Rocio D. Marchese(Merck (Japan))Mark T. Esser(Merck (Japan))Janine T. Bryan(Merck (Japan))Kathrin U. Jansen(Merck (Japan))Heather L. Sings(Merck (Japan))Gretchen Tamms(Merck (Japan))Alfred J. Saah(Merck (Japan))Eliav Barr(Merck (Japan))
Cervical Cancer and HPV ResearchHepatitis B Virus StudiesImmunotherapy and Immune ResponsesVirologyHuman papillomavirus vaccineHuman papillomavirusImmunologyAdministration (probate law)MedicineImmunogenicityBiologyImmune systemCervical cancer
MeSH terms
AdolescentAdultAntibodies, ViralDouble-Blind MethodFemaleHumansViral VaccinesPapillomaviridaePapillomavirus InfectionsHuman papillomavirus 11Human papillomavirus 18Human papillomavirus 16Human papillomavirus 6Papillomavirus Vaccines
Citations
465
FWCI
41.65
field-weighted impact
References
34
Percentile
100%
vs. same field & year
Citations per year
Cited by
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine
Vaccine · 2007 · 455 citations
HPV vaccines – A review of the first decade
Gynecologic Oncology · 2017 · 417 citations
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
British Journal of Cancer · 2006 · 808 citations
Immune responses to human papillomavirus
Vaccine · 2005 · 589 citations
Predictors of HPV vaccine acceptability: A theory-informed, systematic review
Preventive Medicine · 2007 · 857 citations
References
Epidemiology of Genital Human Papillomavirus Infection
The American Journal of Medicine · 1997 · 1,119 citations
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
New England Journal of Medicine · 2003 · 6,258 citations
Comparative analysis of two rates
Statistics in Medicine · 1985 · 1,095 citations
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
JNCI Journal of the National Cancer Institute · 1995 · 3,431 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
